HealthEquity (NASDAQ:HQY) Price Target Cut to $100.00 by Analysts at KeyCorp

HealthEquity (NASDAQ:HQY - Free Report) had its price objective lowered by KeyCorp from $110.00 to $100.00 in a research report released on Wednesday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Other research analysts also recently issued research reports about the stock. Barrington Research reiterated an "outperform" rating and issued a $112.00 target price on shares of HealthEquity in a report on Friday, April 11th. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price objective for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. The Goldman Sachs Group decreased their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. Finally, Wells Fargo & Company lifted their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Buy" and an average price target of $111.75.

HealthEquity Stock Performance

HQY stock traded down $4.31 during midday trading on Wednesday, hitting $80.21. 255,507 shares of the company traded hands, compared to its average volume of 764,257. HealthEquity has a twelve month low of $65.01 and a twelve month high of $115.59. The stock has a market capitalization of $6.94 billion, a price-to-earnings ratio of 73.59, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The business has a 50 day simple moving average of $94.78 and a 200-day simple moving average of $96.55.

Insider Buying and Selling at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares of the company's stock, valued at approximately $6,597,842.85. This trade represents a 6.34 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. The trade was a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 20,381 shares of company stock valued at $1,781,432. 2.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Wealthfront Advisers LLC acquired a new position in HealthEquity during the 4th quarter worth about $10,304,089,000. Vanguard Group Inc. boosted its holdings in HealthEquity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company's stock valued at $861,256,000 after acquiring an additional 99,624 shares during the last quarter. FMR LLC increased its position in HealthEquity by 2.4% in the fourth quarter. FMR LLC now owns 5,415,800 shares of the company's stock worth $519,646,000 after purchasing an additional 125,684 shares during the period. Geode Capital Management LLC raised its holdings in HealthEquity by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company's stock worth $200,522,000 after purchasing an additional 10,421 shares during the last quarter. Finally, Brown Advisory Inc. boosted its stake in shares of HealthEquity by 12.0% in the 4th quarter. Brown Advisory Inc. now owns 2,086,026 shares of the company's stock valued at $200,154,000 after purchasing an additional 224,016 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.